Intravascular Large B-Cell Lymphoma, also known as angioendotheliomatosis proliferans systemisata, is related to b-cell lymphoma and lymphoma. An important gene associated with Intravascular Large B-Cell Lymphoma is BCL6 (BCL6 Transcription Repressor), and among its related pathways/superpathways are Direct p53 effectors and Interleukin-4 and Interleukin-13 signaling. The drugs Prednisone and Rituximab have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and skin.